Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T cells

Preston, Julie, Thorburn, Alison, Starkey, Malcolm, Beckett, Emma, Horvat, Jay, Wade, Margaret, O'Sullivan, Brendan, Thomas, Ranjeny, Beagley, Kenneth, Gibson, Peter, Foster, Paul, & Hansbro, Philip (2011) Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T cells. The European Respiratory Journal, 37(1), pp. 53-64.

View at publisher (open access)


An inverse association exists between some bacterial infections and the prevalence of asthma. We investigated whether Streptococcus pneumoniae infection protects against asthma using mouse models of ovalbumin (OVA)-induced allergic airway disease (AAD).

Mice were intratracheally infected or treated with killed S. pneumoniae before, during or after OVA sensitisation and subsequent challenge. The effects of S. pneumoniae on AAD were assessed.

Infection or treatment with killed S. pneumoniae suppressed hallmark features of AAD, including antigen-specific T-helper cell (Th) type 2 cytokine and antibody responses, peripheral and pulmonary eosinophil accumulation, goblet cell hyperplasia, and airway hyperresponsiveness. The effect of infection on the development of specific features of AAD depended on the timing of infection relative to allergic sensitisation and challenge. Infection induced significant increases in regulatory T-cell (Treg) numbers in lymph nodes, which correlated with the degree of suppression of AAD. Tregs reduced T-cell proliferation and Th2 cytokine release. The suppressive effects of infection were reversed by anti-CD25 treatment.

Respiratory infection or treatment with S. pneumoniae attenuates allergic immune responses and suppresses AAD. These effects may be mediated by S. pneumoniae-induced Tregs. This identifies the potential for the development of therapeutic agents for asthma from S. pneumoniae.

Impact and interest:

37 citations in Scopus
Search Google Scholar™
37 citations in Web of Science®

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

ID Code: 43255
Item Type: Journal Article
Refereed: Yes
Additional Information: Articles free to read on journal website after 18 months
DOI: 10.1183/09031936.00049510
ISSN: 0903-1936
Subjects: Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > CARDIOVASCULAR MEDICINE AND HAEMATOLOGY (110200)
Divisions: Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
Deposited On: 13 Jul 2011 13:10
Last Modified: 03 Feb 2015 04:36

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page